HATU ((1-[Bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium-3-oxid hexafluorophosphate) 99%

Aavish Drugs Private Limited (ADPL) is a dynamic and innovative pharmaceutical company based in India, with a strong focus on the manufacturing of specialty chemicals and intermediates. Established on September 6, 2022, the company has quickly made a name for itself in the industry, offering a range of high-quality products and services to clients both domestically and internationally.

CRO Services: In addition to its manufacturing capabilities, Aavish Drugs Private Limited also offers Contract Research Organization (CRO) services. This allows the company to provide comprehensive support to clients throughout the drug development process, from initial research to final product formulation.

Aavish Drugs Private Limited is committed to maintaining the highest standards of quality and compliance. The company adheres to strict quality control measures and is dedicated to continuous improvement in all aspects of its operations. This commitment to quality is reflected in the company's product range, which is designed to meet the rigorous demands of the global pharmaceutical market.

As a young and growing company, Aavish Drugs Private Limited is poised for significant growth in the coming years. With a focus on innovation, quality, and customer satisfaction, ADPL is well-positioned to expand its product range and services, and to establish itself as a leading player in the global pharmaceutical industry.